Back to search
Cryopyrin-Associated Periodic Syndromes (CAPS)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Cryopyrin-Associated Periodic Syndromes (CAPS) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Cryopyrin-Associated Periodic Syndromes (CAPS) trials you may qualify forBackground: Anakinra is a drug used to treat people with certain diseases that affect their immune systems. Sometimes anakinra can cause proteins under the ski…
Background: Some diseases cause chronic inflammation with intermittent flares in the body. These are called autoinflammatory diseases. They can cause fevers, r…
Circadian rhythms are characterized by the physiology's adaptation to the alternation of day and night, enabling to adapt to the environment. These rhythms are…
This study will evaluate the efficacy, safety, tolerability and pharmacokinetics of JTE-162 administered once daily for 2 weeks in subjects with cryopyrin-assoc…
This is a study to evaluate safety and effectiveness of Ilaris in adult and pediatric patients receiving the drug in a clinical setting for any of the following…
Background: * Urticaria is a common itchy skin disorder that may occur spontaneously or on exposure to a physical trigger (called physical urticaria). * Resear…
This is a study to understand if taking VTX2735 is safe and effective in participants diagnosed with Cryopyrin-Associated Period Syndrome (CAPS). Approximately…
The purpose of this phase II study was to assess the safety, tolerability and efficacy of DFV890 in participants with FCAS.